ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657321 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657321; 2) Community: the network communities that were significantly associated with the response to NSC 657321; 3) Molecule: the relationships between components within communities and NSC 657321; 4) MDR: the compounds that were significantly associated with the NSC 657321.

NSC Compound Enrichment Correlation
NSC 635448 Hydrazinecarbothioamide, 2-[1-(2-pyridinyl)ethylidene]-N,N-dimethyl-, copper bromide complex 0.01456670152525 0.62987128
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.01456670152525 0.6930795
NSC 107124 Camptothecin Derivative 0.0162638908166157 -0.0010702121
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.0162638908166157 0.40389045
NSC 295642 Null 0.0162638908166157 0.16115982
NSC 321206 Null 0.0162638908166157 0.65744641
NSC 332837 Carbamothioic acid, dimethyl-, S-[2-(2,6-dichlorophenyl)-1-oxo-1H-inden-3-yl] ester 0.0162638908166157 0.69035188
NSC 335794 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)butylidene]hydrazide 0.0162638908166157 0.38479665
NSC 609695 bis(3-chloropropyl) disulfide, S,S-dioxide 0.0162638908166157 0.55589488
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0162638908166157 0.72982993
Total:106  Current:50    [First] [Prev] [Next] [Last]